ALBIREO PHARMA, INC.·4

Oct 25, 4:00 PM ET

Mattsson Jan 4

4 · ALBIREO PHARMA, INC. · Filed Oct 25, 2022

Insider Transaction Report

Form 4
Period: 2022-10-24
Mattsson Jan
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2022-10-24$19.58/sh202$3,95457,759 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 33,065 shares of common stock and 24,694 restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION